These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 17896346)

  • 21. Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users.
    Back-Madruga C; Boone KB; Chang L; Grob CS; Lee A; Nations H; Poland RE
    Clin Neuropsychol; 2003 Nov; 17(4):446-59. PubMed ID: 15168910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apparent transient effects of recent "ecstasy" use on cognitive performance and extrapyramidal signs in human subjects.
    Smith RM; Tivarus M; Campbell HL; Hillier A; Beversdorf DQ
    Cogn Behav Neurol; 2006 Sep; 19(3):157-64. PubMed ID: 16957494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Psychiatric and cognitive long-term effects of ecstasy].
    Høiseth G; Løvåsdal Ø; Titze TK; Bramness JG; Bachs L
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):596-8. PubMed ID: 16505868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ecstasy (MDMA) and memory function: a meta-analytic update.
    Laws KR; Kokkalis J
    Hum Psychopharmacol; 2007 Aug; 22(6):381-8. PubMed ID: 17621368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hippocampal remodelling after MDMA neurotoxicity: a single case study.
    Nifosì F; Martinuzzi A; Toffanin T; Costanzo R; Vestri A; Battaglia M; Bertagnoni GE; Lupi A; Amistà P; Carollo C; Perini G
    World J Biol Psychiatry; 2009; 10(4 Pt 3):961-8. PubMed ID: 18609419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDMA use and neurocognition: a meta-analytic review.
    Kalechstein AD; De La Garza R; Mahoney JJ; Fantegrossi WE; Newton TF
    Psychopharmacology (Berl); 2007 Jan; 189(4):531-7. PubMed ID: 17082969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the acute subjective effects of MDMA/ecstasy.
    Baylen CA; Rosenberg H
    Addiction; 2006 Jul; 101(7):933-47. PubMed ID: 16771886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.
    Reneman L; Schilt T; de Win MM; Booij J; Schmand B; van den Brink W; Bakker O
    J Psychopharmacol; 2006 May; 20(3):389-99. PubMed ID: 16574713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
    J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Syllogistic reasoning performance in MDMA (Ecstasy) users.
    Montgomery C; Fisk JE; Newcombe R; Wareing M; Murphy PN
    Exp Clin Psychopharmacol; 2005 May; 13(2):137-45. PubMed ID: 15943546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
    Gouzoulis-Mayfrank E; Daumann J
    J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
    Molero-Chamizo A
    Rev Neurol; 2005 Jul 16-31; 41(2):108-14. PubMed ID: 16028190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance.
    Lamers CT; Ramaekers JG; Muntjewerff ND; Sikkema KL; Samyn N; Read NL; Brookhuis KA; Riedel WJ
    J Psychopharmacol; 2003 Dec; 17(4):379-87. PubMed ID: 14870949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of memory dysfunction in current and 2-year abstinent MDMA users.
    Ward J; Hall K; Haslam C
    J Clin Exp Neuropsychol; 2006 Apr; 28(3):306-24. PubMed ID: 16618622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
    Bedi G; Redman J
    Psychol Med; 2008 Sep; 38(9):1319-30. PubMed ID: 18226286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological function in ecstasy users: a study controlling for polydrug use.
    Roiser JP; Rogers RD; Sahakian BJ
    Psychopharmacology (Berl); 2007 Jan; 189(4):505-16. PubMed ID: 16163532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
    Parrott AC
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1466-84. PubMed ID: 23660456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C; Fisk JE
    J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment.
    Logan BK; Couper FJ
    J Forensic Sci; 2001 Nov; 46(6):1426-33. PubMed ID: 11714155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment.
    Bhattachary S; Powell JH
    Psychol Med; 2001 May; 31(4):647-58. PubMed ID: 11352367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.